Tobacco-Free Youth Act

Implementation of the Family Smoking Prevention and Tobacco Control Act: FDA regulation of tobacco flavors, modified risk products, and tobacco product standards for nicotine; deeming determinations. FDA Tobacco Total Harm Reduction Program. H.R. 293, Youth Vaping Prevention Act; H.R. 1498, the SAFE Kids Act; H.R. 2411 Tobacco to 21 Act; S. 1541, Tobacco-Free Youth Act; H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019, H.R. 2084, SCOTT Act of 2019, all provisions; attention to Continuing Resolution and Agriculture Appropriations bill for possible provisions affecting tobacco user fee program and other tobacco related issues.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

E-cigarette Tax Priority Act (S.2463) Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act (S.1048/H.R.2111) Protecting American Lungs Act of 2019 (H.R. 4742) Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 (H.R. 2339) Quell Underage Inhalation of Toxic Substances Act of 2019 (H.R. 4425) Quit Because of COVID-19 Act (HR 7286/S. 4524) Resources to Prevent Youth Vaping Act (S. 3223/H.R. 5721) Reversing the Youth Tobacco Epidemic Act of 2020 (S. 3174) SCOTT Act of 2019 (H.R.2084) Smoke-Free Schools Act of 2019 (S.1832/H.R.4019) Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act (S.655/H.R.1498) Tobacco-Free Youth Act (S.1541) Tobacco Tax Equity Act (S.2517) To amend title 38, U.S. Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, & for other purposes (S.2106/H.R.3700) Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 (H.R.1854/S.9) Implementation of: The Family Smoking Prevention and Tobacco Control Act (P.L.111-31) The Further Consolidated Appropriations Act of 2020 (P.L. 116-94): Division N, Sec. 603 Minimum age of sale of tobacco products and Sec. 604 Sale of tobacco products to individuals under the age of 21

Client expense: $125,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

S.9 - Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 S.1541 - Tobacco-Free Youth Act S. 1258 - Tobacco to 21 Act H.R.4425 - Quell Underage Inhaling of Toxic Substances Act of 2019 H.R. 1854 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 S.1965 - Combating the Illicit Trade in Tobacco Products Act S.2517 - Tobacco Tax Equity Act of 2019 H.R.2339 - Reversing the Youth Tobacco Epidemic Act of 2019 General Tobacco Related Activities Tobacco Taxation Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems Deeming Rule Deemed Product Warning Labels Premarket Review of Tobacco Products Substantial Equivalence of Tobacco Products Tobacco 21 H.R.6201 - Families First Coronavirus Response Act Cornavirus Response Paycheck Protection Program S. 3548 CARES Act PPP Flexibilty Act H.R. 7011 Pandemic Risk Insurance Act Business Reopening Guidelines Business Liability Protection Entertainment, Business, and Travel Tax Credits Continued Postponement of Deadlines for Certain Tax Filings and Collection Tax Deduction for Business Expenses related to Social Distancing, Hygiene and Sanitation The Health, Economic Assistance, Liability Protection and Schools Act Cornavirus Relief Packages

Client expense: $30,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office

H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, medical malpractice reform, the impact on small business, section 1557 on nondiscrimination, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; Medicare hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; distribution of COVID-19 vaccines; comments on notice of proposed rulemaking: securing updated and necessary statutory evaluations timely (SUNSET); reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization; COVID-19 liability issues; Phase IV COVID-19 relief legislation and civil liability issues affecting the business community

Client expense: $22,290,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Reserve System, Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

H.Res.896, Reaffirming support of fundamental United States principles at the United Nations and encouraging the World Health Organization to embrace technological advancements in tobacco control H.R. 293, Youth Vaping Prevention Act S. 655/H.R. 1498, SAFE Kids Act S. 1965/H.R. 1642, Combatting Illicit Trade in Tobacco Products Act S. 916/H.R. 1897, MOMMAS Act; provisions related to the taxation of tobacco products H.R. 2084, Stopping Consumption of Tobacco by Teens (SCOTT) Act S. 1048/H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act H.R. 2726, Banning Smoking on Amtrak Act S. 1823/H.R. 3229, Children Dont Belong on Tobacco Farms Act S. 1253/H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act S. 1832/H.R. 4019, Smoke-Free Schools Act H.R. 4249, Stop Vaping Ads Act S. 2517/H.R. 4425, Tobacco Tax Parity Act/Quell Underage Inhaling of Toxic Substances (QUITS) Act H.R. 4624, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act H.R. 4742, Imposition of Tax on Nicotine for Use in Vapor Act H.R. 5005, Prevent Vape Use Act S. 3096/H.R. 5482, PREVENT (Providing Resources to End the Vaping Epidemic Now for Teenagers) Act S. 3223/H.R. 5721, Resources to Prevent Youth Vaping Act S. 3263/H.R. 5845, Break Free from Plastic Pollution Act H.R. 5963, E-Cigarette Oversight and Accountability Act S. 616, E-Cigarette Youth Protection Act S. 1258/H.R. 2411, Tobacco to 21 Act S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2463, E-Cigarette Tax Parity Act S. 2519, Ending New Nicotine Dependencies (ENND) Act S. 2536, E-Cigarette Device Standards Act S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.4524 - Quit Because of COVID-19 Act H.R.8137 - Accurate Reporting of Smoking Variants Act of 2020 H.R.8343 - To amend the Federal Food, Drug, and Cosmetic Act to require the Secretary to refer each application for review of certain tobacco products to the Tobacco Products Scientific Advisory Committee, and for other purposes. Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA PMTA and MRTP compliance policies Issues surrounding taxation of tobacco products January 2020 FDA guidance on flavors in vapor products Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act January 2020 FDA guidance on flavors in vapor products FDA proposed rule concerning NNN Levels in Smokeless Tobacco Products ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001

Client expense: $380,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Tobacco issues in general S. 1541, The Tobacco Free Youth Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 2411, Tobacco to 21 Act HR 4742, Protecting American Lungs Act of 2019

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Tobacco issues in general S.1541, Tobacco-Free Youth Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 2411, The Tobacco to 21 Act HR 4742, Protecting American Lungs Act of 2019

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 9 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 S. 1541 Tobacco Free Youth Act S. 1258 / H.R. 2411 Tobacco to 21 Act S. 655, SAFE Kids Act H.R. 2084 To amend the Federal Food, Drug, and Cosmetic Act to raise the minimum age restriction with respect to the sale of tobacco products, and for other purposes. H.R. 1854 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 FDA Tobacco Deeming Rule HR 2411 Tobacco to 21 Act H.R. 2339 Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 293 Youth Vaping Prevention Act of 2019 H.R. 1498 / S. 655 SAFE Kids Act H.R. 4272 H.R. 2463 HR 1856 Domestic Priorities and International Assistance Minibus Appropriations, Title F, section 605, Sale of Tobacco Products to Individuals under age of 21. Guidance on Flavored Cigars Cigar Excise Taxes

Client expense: $45,000 · Firm income: Not reported

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Ending Nicotine Dependence from Electronic Delivery Systems (End ENDS) Act (H.R. 4264), Reversing the Youth Tobacco Epidemic Act (H.R. 2339/S. 3174), SAFE Kids Act (H.R. 1498/S. 655), Smoke Free Schools Act (S. 1832/H.R. 4019), Tobacco Free Youth Act (S. 1541), Protecting American Lungs Act (H.R. 4742), Quit Because of COVID-19 Act (H.R. 7286), Independent Advisory Committee Review of E-Cigarettes Applications Act (H.R. 8343), e-cigarettes, and premarket application of tobacco products

Client expense: $30,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

HR 2084 To amend the Federal Food, Drug and Cosmetic Act to raise the minimum age restriction with respect to the sale of tobacco products, and for other purposes S. 9 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 H.R. 1854 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 FDA Tobacco Deeming Rule HR 2411, Tobacco to 21 Act HR 2339, Reversing the Youth Tobacco Epidemic Act of 2019 HR 293, Youth Vaping Prevention Act HR 1498, SAFE Kids Act S 1258, Tobacco to 21 Act S 1541, Tobacco Free Youth Act S. 655, SAFE Kids Act HR 1856, Domestic Priorities and International Assistance Minibus Appropriations, Title F, section 605, Sale of Tobacco Products to Individuals under age of 21.

Client expense: Not reported · Firm income: $40,000

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues

Client expense: $20,000,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

Tobacco issues in general S.1541, Tobacco-Free Youth Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 2411, The Tobacco to 21 Act HR 4742, Protecting American Lungs Act of 2019

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 597: Marijuana Justice Act of 2019. This bill would remove marijuana as a Schedule I drug under the Controlled Substances Act. Monitor. S.655: Stopping Appealing Flavors in E-Cigarettes for Kids Act. This bill would restrict flavors in non-cigarette tobacco products. Monitor. S.1048. Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. This bill would require research on youth e-cigarette use. Monitor. S.1253: Preventing Online Sales of E-Cigarettes to Children Act. This bill would apply regulations on online tobacco sales to e-cigarette products. Monitor. S 1258: Tobacco to 21 Act. This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. S1541: "Tobacco-Free Youth Act." This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. S1832: Smoke-Free Schools Act of 2019. This bill amends the tobacco-free schools law to include the use of e-cigarettes. Monitor. S2106: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S2519: Ending New Nicotine Dependencies Act of 2019. This bill would prohibit the sale of non-tobacco e-cigarette flavors. Monitor. S2768: Banning Smoking on Amtrak Act of 2019. This bill would prohibit smoking including the use of e-cigarettes on Amtrak trains. Monitor. S2865: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S3174: Reversing the Youth Tobacco Epidemic Act of 2020. This bill regulates but does not prohibit the sale of flavored tobacco and vaping products. Monitor. HR 293: Youth Vaping Prevention Act of 2019. This bill would restrict flavors in non-cigarette tobacco products, and apply the Jenkins Act to e-cigarette products. Monitor. HR 1456: Marijuana Justice Act of 2019. This bill would remove marijuana as a Schedule I drug under the Controlled Substances Act. Monitor. HR 1498: Stopping Appealing Flavors in E-Cigarettes for Kids Act. This bill would restrict flavors in non-cigarette tobacco products. Monitor. HR 2084: Stopping Consumption of Tobacco by Teens Act of 2019. This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. HR 2111: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. This bill would require research on youth e-cigarette use. Monitor. H.R.2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020. This bill would restrict flavors in tobacco products and some vaping products, and other regulations. Monitor. HR 2411: Tobacco to 21 Act. This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. HR 2338: Marijuana in Federally Assisted Housing Parity Act of 2019. This bill would regulate marijuana in federally assisted housing, including prohibiting smoking marijuana where smoking of tobacco is prohibited. Monitor. HR 2339: Reversing the Youth Tobacco Epidemic Act of 2019. This bill would increase the age of sale for tobacco products from 18 to 21, restrict flavors in tobacco products, and other regulations. Monitor. HR 2726: Banning Smoking on Amtrak Act of 2019. This bill would prohibit smoking including the use of e-cigarettes on Amtrak trains. Monitor. HR 3700: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. HR 3942: Preventing Online Sales of E-Cigarettes to Children Act. This bill would apply regulations on online tobacco sales to e-cigarette products. Monitor. HR 4019: Smoke-Free Schools Act of 2019. This bill would amend the tobacco-free schools law to include the use of e-cigarettes. Monitor. HR 4425: Quell Underage Inhaling of Toxic Substances Act of 2019. This bill would prohibit the flavoring of certain tobacco products. Monitor. HR 4689: Smoke Free Affordable Housing Act. This bill would require state allocation plans to favor smokefree buildings. Monitor. HR 5005: Preventing Vape Use Act. This bill would require a recall of e-cigarettes that have not been subject to premarket review.

Client expense: Not reported · Firm income: Not reported

Legislation related to the opioid epidemic. Legislation related to oral health literacy. H.R.293 - Youth Vaping Prevention Act of 2019 H.R.2339 - Reversing Youth Tobacco Epidemic Act of 2019 S.1541 - Tobacco-Free Youth Act S.1266 - Protecting Patients from Surprise Medical Bills Act S.3096 & H.R.5482 - PREVENT Act of 2020 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Occupational Safety & Health Administration (OSHA), SENATE, Treasury, Dept of

H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues

Client expense: $20,000,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1.Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2.Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 3.Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111-296) 4.Implementation of Every Student Succeeds Act (Public Law 114-95) 5.Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 6.Midnight Rules Relief Act (S.34/H.R. 21) 7.Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 8.Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 9.Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 10.Regulatory Integrity Act (H.R. 1004) 11.OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 12.A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 13.American Health Care Act (H.R. 1628/H.Res. 228) 14.Ozone Standards Implementation Act (S. 263/H.R. 806) 15.Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 16.Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 17.Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 18.Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 19.Preventing Antibiotic Resistance Act (S. 629) 20.Better Care Reconciliation Act (H.R. 1628) and related amendments 21.Public Health Emergency Response Act (S. 196) 22.Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 23.Treat and Reduce Obesity Act (S. 830/H.R. 1953) 24.Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 25.Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 26.Tobacco Tax Equity Act (S. 1837) 27.Healthy Kids Act (S. 1821/H.R. 3921) 28.Implementation of the Drug Quality and Security Act (P.S. 113-54) 29.Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 30.Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 31.Lead-Safe Housing for Kids Act (S. 1845) 32.Supporting Working Moms Act (S. 2122/H.R. 3255) 33.Championing Healthy Kids Act (H.R. 3922) 34.Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 35.An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115-96) 36.Tax Cuts and Jobs Act (Public Law 115-97) 37.Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 38.Vaccine Access Improvement Act (H.R. 4993) 39.Relief from New Source Performance Standards Act (H.R. 453) 40.Strategies to Address Antimicrobial Resistance (S. 2469) 41.Opioid Quota Reform Act (S. 2535) 42.Hospital Preparedness Program Reauthorization Act (H.R. 4776) 43.Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 44.Opioid Crisis Response Act of 2018 (S. 2680) 45.Agriculture and Nutrition Act (H.R. 2) 46.Agriculture Improvement Act (S. 3042) 47.SECURE Act (H.R. 5998) 48.Trauma-Informed Care for Children and Families Act (S. 774) 49.SUPPORT for Patients and Communities Act (H.R. 6) 50.Centers for Disease Control Emergency Response Act (S. 3161) 51.LABEL Opioids Act (S. 3428) 52.Relief from New Source Performance Standards Act (S. 1857) 53.Outdoors for All Act (S. 3499) 54.The MOMMA Act (H.R. 5977) 55.Preventing Maternal Deaths Act (H.R. 1318) 56.Medicare Access to Vaccines Equity Act (not yet introduced) 57.The Support Act (H.R. 6) 58.Climate Change Health Protection and Promotion Act (S. 529) 59.NURSE Act (H.R. 1597) 60.Investing for the People Act (H.R. 2021) 61.Child Care for Working Families Act (H.R. 365/S. 568) 62.FAMILY Act (H.R. 1185/S. 463) 63.Transportation Alternatives Enhancement Act (S. 1098) 64.Lower Health Care Costs Act (S. 1895) 65.LIFT America Act (H.R 2479) 66.Public Health Funding Restoration Act (H.R. 3447/S. 1944) 67.Supporting Older Americans Act of 2020 (HR 4334) 68.Campus Prevention and Recovery Services for Students Act (H.R. 3591) 69.Healthier Students for Stronger Campuses Act (S. 1281) 70.Saving Lives Through Better Data Act (S. 1793) 71.VACCINES Act (H.R. 2862) 72.DISARM Act (H.R. 4100/S. 1712) 73.Community Access, Resources, and Education for Families Act (H.R. 3117) 74.Protecting Seniors Through Immunization Act (S. 1872) 75.Tobacco-Free Youth Act (S. 1541) 76.Tobacco to 21 Act (H.R. 2411/S. 1258) 77.Investing for People Act (H.R. 2021) 78.School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 79.Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) 80.Social Determinants Accelerator Act (H.R. 4004/S. 2986) 81.Mental Health Professionals Workforce Shortage Loan Repayment Act (H.R. 2431) 82.The UNDERSTAND Act (S. 1323) 83.Americas Transportation Infrastructure Act (S. 2302) 84.Barriers to Suicide Act of 2019 (H.R. 4309) 85.Promoting Physical Activity for Americans Act (S. 1608/H.R. 2891) 86.Public Health Infrastructure Modernization Act of 2019 (H.R. 5321) 87.Supporting Healthy Mothers and Infants Act (H.R. 5249) 88.Lead-Free Future Act (H.R. 4416) 89.Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R. 4768) 90.Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide (H. Res. 592) 91.Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) 92.Families First Coronavirus Response Act (H.R. 6201) 93.Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748) 94.Connecting Americas Transportation Infrastructure Act (H.R. 5696/S. 3391)) 95.Improving Access to Remote Behavioral Health Treatment Act (S. 2244/H.R. 4131) 96.National Suicide Hotline Designation Act (S. 2661/H.R. 4194) 97.Suicide Prevention Lifeline Improvement Act (H.R. 4564) 98.Campaign to Prevent Suicide Act (H.R. 4585) 99.Medicaid Reentry Act (H.R. 1329) 100.Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767) 101.Mental Health Services for Students Act (S. 1122/H.R. 1109) 102.Suicide Training and Awareness Nationally Delivered for Universal Prevention (STANDUP) Act (S. 2492/H.R. 2599) 103.Mental Health Parity Compliance Act (S. 1737/H.R. 3165) 104.Behavioral Health Transparency Act (S. 1576/H.R. 2874) 105.Medicare Mental Health Access Act (S. 2772/H.R. 884) 106.Public Health Emergency Response and Accountability Act (S. 3309) 107.Family Violence Prevention and Services Improvement Act (H.R. 5041) 108.Protecting the Health of Americas Older Adults During COVID-19 and Beyond Act (H.R. 6935) 109.Improving Social Determinants Act (H.R. 6561/S. 4440) 110.Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H.Con.Res.100) 111.FY 2021 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (TBD) 112.Better Tools for Healthy Living Act (S. 1805) 113.The WIC Act (H.R. 6811/S. 2358) 114.Health Equity and Accountability Act (H.R. 6637) 115.Paycheck Protection Program and Health Care Enhancement Act (H.R. 266) 116.The HEROES Act (H.R.6800) 117.Community Solutions for COVID-19 Act (H.R.7077/S.3877) 118.The Black Maternal Health Momnibus Act of 2020 (H.R. 6142) 119.COVID-19 Bias and Anti-Racism Training Act (H.R. 7618/S. 4248) 120.Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H. Con. Res. 100) 121.Community Immunity During COVID-19 Act of 2020 (H.R. 8061) 122.Public Safety Officer Support Act (H.R. 7568) 123.COVID-19 Behavioral Health Support Act (S. 4059) 124.Public Health Workforce Loan Repayment Act (H.R. 6578) 125.Strengthening the Public Health Workforce Act (S. 3737) 126.A resolution declaring racism a public health crisis (S. Res. 655) 127.Pandemic Child Hunger Prevention Act (H.R.7887) 128.Public Health Infrastructure Saves Lives Act (S. 4740) 129.CARE for Families Act (H.R. 3117/S. 3354) 130.Improving Data Collection for Adverse Childhood Experiences Act (H.R. 7689) 131.The STANDUP Act of 2020 (H.R. 7293) 132.The Effective Suicide Screening and Assessment in the Emergency Department Act (H.R. 4861) 133.The Pursuing Equity in Mental Health Act of 2019 (H.R. 5469) 134.The Improving Mental Health Access from the Emergency Department Act (H.R. 2519/S. 1334) 135.The Suicide Prevention Act (H.R. 5619/S. 3198) 136.The Helping Emergency Responders Overcome (HERO) Act (H.R. 1646/S. 3244) 137.The Campaign to Prevent Suicide Act (H.R. 4585) 138.The Maternal Health Immunization Enhancement Act (S. 4690) 139.Pandemic Vaccine Access Improvement Act (Not yet introduced) 140.Moving Forward Act (H.R. 2) 141.Continuing Appropriations Act, 2021 and Other Extensions Act (HR 8319) Coronavirus Response Additional Supplemental Appropriations Act (S. 4320). 142.ETHIC Act (H.R. 8205) 143.Safely Back to School and Work Act (S. 4322) 144.Supporting the goals and ideals of BIPOC Mental Health Awareness Month (H.Res. 1064) 145.COVID-19 Health Disparities Action Act (S. 4262) 146.Protecting American Heroes Act of 2020 (S. 4368) 147.Health STATISTICS Act (H.R. 8080) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, NIMH, Education, USDA, DHS, FEMA, and SAMHSA.

Client expense: $36,974 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)

S. 9 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 S. 1541 Tobacco Free Youth Act S. 1258 / H.R. 2411 Tobacco to 21 Act S. 655, SAFE Kids Act H.R. 2084 To amend the Federal Food, Drug, and Cosmetic Act to raise the minimum age restriction with respect to the sale of tobacco products, and for other purposes. H.R. 1854 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 FDA Tobacco Deeming Rule HR 2411 Tobacco to 21 Act H.R. 2339 Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 293 Youth Vaping Prevention Act of 2019 H.R. 1498 / S. 655 SAFE Kids Act H.R. 4272 H.R. 2463 HR 1856 Domestic Priorities and International Assistance Minibus Appropriations, Title F, section 605, Sale of Tobacco Products to Individuals under age of 21. Guidance on Flavored Cigars Cigar Excise Taxes

Client expense: $45,000 · Firm income: Not reported

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Legislation and policies related to: Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices Stopping Consumption of Tobacco by Teens (SCOTT) Act of 2019 (H.R. 2084) Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) Preventing Online Sales of E-Cigarettes to Children Act (H.R. 3942/S. 1253) Quell Underage Inhaling of Toxic Substances (QUITS) Act of 2019 (H.R. 4425) Protecting American Lungs Act (H.R. 4742) E-Cigarette Youth Protection Act (S. 616) Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act (S. 655/H.R. 1498) Tobacco to 21 Act (S. 1258/H.R. 2411) Tobacco-Free Youth Act (S. 1541)

Client expense: Not reported · Firm income: $24,000

Government targets: Bureau of Alcohol Tobacco Firearms & Explosives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office

E-cigarette Tax Priority Act (S.2463) Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act (S.1048/H.R.2111) Protecting American Lungs Act of 2019 (H.R. 4742) Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 (H.R. 2339) Quell Underage Inhalation of Toxic Substances Act of 2019 (H.R. 4425) Quit Because of COVID-19 Act (HR 7286/S. 4524) Resources to Prevent Youth Vaping Act (S. 3223/H.R. 5721) Reversing the Youth Tobacco Epidemic Act of 2020 (S. 3174) SCOTT Act of 2019 (H.R.2084) Smoke-Free Schools Act of 2019 (S.1832/H.R.4019) Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act (S.655/H.R.1498) Tobacco-Free Youth Act (S.1541) Tobacco Tax Equity Act (S.2517) To amend title 38, U.S. Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, & for other purposes (S.2106/H.R.3700) Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 (H.R.1854/S.9) Implementation of: The Family Smoking Prevention and Tobacco Control Act (P.L.111-31) The Further Consolidated Appropriations Act of 2020 (P.L. 116-94): Division N, Sec. 603 Minimum age of sale of tobacco products and Sec. 604 Sale of tobacco products to individuals under the age of 21

Client expense: $170,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Interior, Dept of (DOI), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

H.Res.896, Reaffirming support of fundamental United States principles at the United Nations and encouraging the World Health Organization to embrace technological advancements in tobacco control H.R. 293, Youth Vaping Prevention Act S. 655/H.R. 1498, SAFE Kids Act S. 1965/H.R. 1642, Combatting Illicit Trade in Tobacco Products Act S. 916/H.R. 1897, MOMMAS Act; provisions related to the taxation of tobacco products H.R. 2084, Stopping Consumption of Tobacco by Teens (SCOTT) Act S. 1048/H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act H.R. 2726, Banning Smoking on Amtrak Act S. 1823/H.R. 3229, Children Dont Belong on Tobacco Farms Act S. 1253/H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act S. 1832/H.R. 4019, Smoke-Free Schools Act H.R. 4249, Stop Vaping Ads Act S. 2517/H.R. 4425, Tobacco Tax Parity Act/Quell Underage Inhaling of Toxic Substances (QUITS) Act H.R. 4624, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act H.R. 4742, Imposition of Tax on Nicotine for Use in Vapor Act H.R. 5005, Prevent Vape Use Act S. 3096/H.R. 5482, PREVENT (Providing Resources to End the Vaping Epidemic Now for Teenagers) Act S. 3223/H.R. 5721, Resources to Prevent Youth Vaping Act S. 3263/H.R. 5845, Break Free from Plastic Pollution Act H.R. 5963, E-Cigarette Oversight and Accountability Act S. 616, E-Cigarette Youth Protection Act S. 1258/H.R. 2411, Tobacco to 21 Act S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2463, E-Cigarette Tax Parity Act S. 2519, Ending New Nicotine Dependencies (ENND) Act S. 2536, E-Cigarette Device Standards Act S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act S.4524 - Quit Because of COVID-19 Act H.R.8137 - Accurate Reporting of Smoking Variants Act of 2020 H.R.8343 - To amend the Federal Food, Drug, and Cosmetic Act to require the Secretary to refer each application for review of certain tobacco products to the Tobacco Products Scientific Advisory Committee, and for other purposes. Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA PMTA and MRTP compliance policies Issues surrounding taxation of tobacco products January 2020 FDA guidance on flavors in vapor products Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act January 2020 FDA guidance on flavors in vapor products FDA proposed rule concerning NNN Levels in Smokeless Tobacco Products ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001

Client expense: $360,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

HR 2084 To amend the Federal Food, Drug and Cosmetic Act to raise the minimum age restriction with respect to the sale of tobacco products, and for other purposes S. 9 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 H.R. 1854 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 FDA Tobacco Deeming Rule HR 2411, Tobacco to 21 Act HR 2339, Reversing the Youth Tobacco Epidemic Act of 2019 HR 293, Youth Vaping Prevention Act HR 1498, SAFE Kids Act S 1258, Tobacco to 21 Act S 1541, Tobacco Free Youth Act S. 655, SAFE Kids Act HR 1856, Domestic Priorities and International Assistance Minibus Appropriations, Title F, section 605, Sale of Tobacco Products to Individuals under age of 21.

Client expense: Not reported · Firm income: $40,000

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE

Ending Nicotine Dependence from Electronic Delivery Systems (End ENDS) Act (H.R. 4264), Reversing the Youth Tobacco Epidemic Act (H.R. 2339/S. 3174), SAFE Kids Act (H.R. 1498/S. 655), Smoke Free Schools Act (S. 1832/H.R. 4019), Tobacco Free Youth Act (S. 1541), Protecting American Lungs Act (H.R. 4742), Quit Because of COVID-19 Act (H.R. 7286), Independent Advisory Committee Review of E-Cigarettes Applications Act (H.R. 8343), e-cigarettes, and premarket application of tobacco products

Client expense: $60,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

Implementation of the Family Smoking Prevention and Tobacco Control Act: FDA regulation of tobacco flavors, modified risk products, and tobacco product standards for nicotine; deeming determinations. FDA Tobacco Total Harm Reduction Program. H.R. 293, Youth Vaping Prevention Act; H.R. 1498, the SAFE Kids Act; H.R. 2411 Tobacco to 21 Act; S. 1541, Tobacco-Free Youth Act; H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019, H.R. 2084, SCOTT Act of 2019, all provisions; attention to Continuing Resolution and Agriculture Appropriations bill for possible provisions affecting tobacco user fee program and other tobacco related issues.

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES

H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021 S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 178, UIGHUR Act of 2019, including provisions relating to substitute amendment regarding COVID-19 relief package S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 S. 4317, Safeguarding Americas Frontline Employees To Offer Work Opportunities Required to Kickstart the Economy (SAFE TO WORK) Act Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Fed, Reg. 16,834, April 23, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; proposals to expand Medicare including Medicare Buy-In and the development of a public option; medical hospital outpatient prospective payment system for CY 2020; drug pricing including most-favored nations proposals, international pricing index, importation and mandatory rebates; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments to the U.S. Department of Health and Human Services on the declaration under the Public Readiness and Emergency Preparedness (PREP) Act for medical countermeasures against COVID-19, as amended on April 10, 2020 and June 8, 2020 (Declaration), Section 319F-3 of the Public Health Service (PHS) Act (42 U.S.C. 247d-6d); comments to the U.S. Department of Health and Human Services on CMS-2393-P: Medicaid Program; Medicaid fiscal accountability regulation; comments to the U.S. Department of Health and Human Services on the Administrations proposed rule to eliminate drug manufacturer rebates in Part D; transparency in coverage; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use; reform of the World Health Organization (WHO); continued U.S. membership in the World Health Organization Public Readiness and Emergency Preparedness Act (P.L. 109-148, Division C), and COVID -19; potential legislation dealing with COVID-19 liability issues

Client expense: $20,000,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

S.9 - Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 S.1541 - Tobacco-Free Youth Act S. 1258 - Tobacco to 21 Act H.R.4425 - Quell Underage Inhaling of Toxic Substances Act of 2019 H.R. 1854 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 S.1965 - Combating the Illicit Trade in Tobacco Products Act S.2517 - Tobacco Tax Equity Act of 2019 H.R.2339 - Reversing the Youth Tobacco Epidemic Act of 2019 General Tobacco Related Activities Tobacco Taxation Premarket Tobacco Product Applications for Electronic Nicotine Delivery Systems Deeming Rule Deemed Product Warning Labels Premarket Review of Tobacco Products Substantial Equivalence of Tobacco Products Tobacco 21 H.R.6201 - Families First Coronavirus Response Act Cornavirus Response Paycheck Protection Program S. 3548 CARES Act PPP Flexibilty Act H.R. 7011 Pandemic Risk Insurance Act Business Reopening Guidelines Business Liability Protection Entertainment, Business, and Travel Tax Credits Continued Postponement of Deadlines for Certain Tax Filings and Collection Tax Deduction for Business Expenses related to Social Distancing, Hygiene and Sanitation The Health, Economic Assistance, Liability Protection and Schools Act

Client expense: $35,000 · Firm income: Not reported

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Office of Personnel Management (OPM), Office of the Vice President of the United States, SENATE, Small Business Administration (SBA), Treasury, Dept of, White House Office

P.L. 111-31 - Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act - implementation of provisions relating to federal regulation of tobacco; H.R. 7608 - Division B - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 - Title VI - Food and Drug Administration - provisions related to federal regulation of tobacco; S. 655 and H.R. 1498 - SAFE Kids Act - a bill imposing additional restrictions on flavors in e-cigarettes; S. 616 - E-Cigarette Youth Protection Act - a bill imposing user fees on e-cigarette manufacturers; H.R. 2339 - Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 - all provisions; S. 1541 - Tobacco Free Youth Act - entire bill increasing minimum age for sale of tobacco products to 21; H.R. 4742 - To amend the Internal Revenue Code of 1986 to impose a tax on nicotine used in vaping, etc. - entire bill; 81 FR 289783 (May 10, 2016) - Implementation of Food and Drug Administration final rule deeming certain tobacco products, including electronic cigarettes, as subject to FDA regulation.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

P.L. 111-31 - Family Smoking Prevention and Tobacco Control and Federal Retirement Reform Act - implementation of provisions relating to federal regulation of tobacco; H.R. 7608 - Division B - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2021 - Title VI - Food and Drug Administration - provisions related to federal regulation of tobacco; H.R. 2339 - Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 - all provisions; S. 1541 - Tobacco Free Youth Act - entire bill increasing minimum age for sale of tobacco products to 21; 81 FR 289783 (May 10, 2016) - Implementation of Food and Drug Administration final rule deeming certain tobacco products, including electronic cigarettes, as subject to FDA regulation.

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Tobacco issues in general S. 1541, The Tobacco Free Youth Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 2411, Tobacco to 21 Act HR 4742, Protecting American Lungs Act of 2019

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Tobacco issues in general S.1541, Tobacco-Free Youth Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 2411, The Tobacco to 21 Act HR 4742, Protecting American Lungs Act of 2019

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S 597: Marijuana Justice Act of 2019. This bill would remove marijuana as a Schedule I drug under the Controlled Substances Act. Monitor. S.655: Stopping Appealing Flavors in E-Cigarettes for Kids Act. This bill would restrict flavors in non-cigarette tobacco products. Monitor. S.1048. Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. This bill would require research on youth e-cigarette use. Monitor. S.1253: Preventing Online Sales of E-Cigarettes to Children Act. This bill would apply regulations on online tobacco sales to e-cigarette products. Monitor. S 1258: Tobacco to 21 Act. This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. S1541: "Tobacco-Free Youth Act." This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. S1832: Smoke-Free Schools Act of 2019. This bill amends the tobacco-free schools law to include the use of e-cigarettes. Monitor. S2106: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S2519: Ending New Nicotine Dependencies Act of 2019. This bill would prohibit the sale of non-tobacco e-cigarette flavors. Monitor. S2768: Banning Smoking on Amtrak Act of 2019. This bill would prohibit smoking including the use of e-cigarettes on Amtrak trains. Monitor. S2865: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. S3174: Reversing the Youth Tobacco Epidemic Act of 2020. This bill regulates but does not prohibit the sale of flavored tobacco and vaping products. Monitor. HR 293: Youth Vaping Prevention Act of 2019. This bill would restrict flavors in non-cigarette tobacco products, and apply the Jenkins Act to e-cigarette products. Monitor. HR 1456: Marijuana Justice Act of 2019. This bill would remove marijuana as a Schedule I drug under the Controlled Substances Act. Monitor. HR 1498: Stopping Appealing Flavors in E-Cigarettes for Kids Act. This bill would restrict flavors in non-cigarette tobacco products. Monitor. HR 2084: Stopping Consumption of Tobacco by Teens Act of 2019. This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. HR 2111: Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction. This bill would require research on youth e-cigarette use. Monitor. H.R.2339: Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020. This bill would restrict flavors in tobacco products and some vaping products, and other regulations. Monitor. HR 2411: Tobacco to 21 Act. This bill would increase the age of sale for tobacco products from 18 to 21. Monitor. HR 2338: Marijuana in Federally Assisted Housing Parity Act of 2019. This bill would regulate marijuana in federally assisted housing, including prohibiting smoking marijuana where smoking of tobacco is prohibited. Monitor. HR 2339: Reversing the Youth Tobacco Epidemic Act of 2019. This bill would increase the age of sale for tobacco products from 18 to 21, restrict flavors in tobacco products, and other regulations. Monitor. HR 2726: Banning Smoking on Amtrak Act of 2019. This bill would prohibit smoking including the use of e-cigarettes on Amtrak trains. Monitor. HR 3700: This bill would prohibit smoking on the premises of any facility of the Veterans Health Administration. Monitor. HR 3942: Preventing Online Sales of E-Cigarettes to Children Act. This bill would apply regulations on online tobacco sales to e-cigarette products. Monitor. HR 4019: Smoke-Free Schools Act of 2019. This bill would amend the tobacco-free schools law to include the use of e-cigarettes. Monitor. HR 4425: Quell Underage Inhaling of Toxic Substances Act of 2019. This bill would prohibit the flavoring of certain tobacco products. Monitor. HR 4689: Smoke Free Affordable Housing Act. This bill would require state allocation plans to favor smokefree buildings. Monitor. HR 5005: Preventing Vape Use Act. This bill would require a recall of e-cigarettes that have not been subject to premarket review.

Client expense: Not reported · Firm income: Not reported

Legislation related to the opioid epidemic. Legislation related to oral health literacy. H.R.293 - Youth Vaping Prevention Act of 2019 H.R.2339 - Reversing Youth Tobacco Epidemic Act of 2019 S.1541 - Tobacco-Free Youth Act S.1266 - Protecting Patients from Surprise Medical Bills Act S.3096 & H.R.5482 - PREVENT Act of 2020 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act

Client expense: Not reported · Firm income: $20,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Occupational Safety & Health Administration (OSHA), SENATE, Treasury, Dept of

Legislation and policies related to: Promotion of cessation of tobacco use and smoking, including e-cigarettes and vaping devices Preventing child and youth access to and use of tobacco products including e-cigarettes and vaping devices Stopping Consumption of Tobacco by Teens (SCOTT) Act of 2019 (H.R. 2084) Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) Preventing Online Sales of E-Cigarettes to Children Act (H.R. 3942/S. 1253) Quell Underage Inhaling of Toxic Substances (QUITS) Act of 2019 (H.R. 4425) Protecting American Lungs Act (H.R. 4742) E-Cigarette Youth Protection Act (S. 616) Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act (S. 655/H.R. 1498) Tobacco to 21 Act (S. 1258/H.R. 2411) Tobacco-Free Youth Act (S. 1541)

Client expense: Not reported · Firm income: $24,000

Government targets: Bureau of Alcohol Tobacco Firearms & Explosives, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, Veterans Affairs, Dept of (VA), Vice President of the U.S., White House Office

E-cigarette Tax Priority Act (S.2463) Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act (S.1048/H.R.2111) Protecting American Lungs Act of 2019 (H.R. 4742) Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 (H.R. 2339) Quell Underage Inhalation of Toxic Substances Act of 2019 (H.R. 4425) Quit Because of COVID-19 Act (HR 7286) Resources to Prevent Youth Vaping Act (S. 3223/H.R. 5721) Reversing the Youth Tobacco Epidemic Act of 2020 (S. 3174) SCOTT Act of 2019 (H.R.2084) Smoke-Free Schools Act of 2019 (S.1832/H.R.4019) Stopping Appealing Flavors in E-Cigarettes for Kids (SAFE Kids) Act (S.655/H.R.1498) Tobacco-Free Youth Act (S.1541) Tobacco Tax Equity Act (S.2517) To amend title 38, U.S. Code, to prohibit smoking on the premises of any facility of the Veterans Health Administration, & for other purposes (S.2106/H.R.3700) Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 (H.R.1854/S.9) Implementation of: The Family Smoking Prevention and Tobacco Control Act (P.L.111-31)

Client expense: $582,750 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT), Treasury, Dept of, Veterans Affairs, Dept of (VA), White House Office

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2. Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 3. Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111- 296) 4. Implementation of Every Student Succeeds Act (Public Law 114-95) 5. Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 6. Midnight Rules Relief Act (S.34/H.R. 21) 7. Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 8. Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 9. Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 10. Regulatory Integrity Act (H.R. 1004) 11. OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 12. A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 13. American Health Care Act (H.R. 1628/H.Res. 228) 14. Ozone Standards Implementation Act (S. 263/H.R. 806) 15. Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 16. Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 17. Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 18. Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 19. Preventing Antibiotic Resistance Act (S. 629) 20. Better Care Reconciliation Act (H.R. 1628) and related amendments 21. Public Health Emergency Response Act (S. 196) 22. Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 23. Treat and Reduce Obesity Act (S. 830/H.R. 1953) 24. Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 25. Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 26. Tobacco Tax Equity Act (S. 1837) 27. Healthy Kids Act (S. 1821/H.R. 3921) 28. Implementation of the Drug Quality and Security Act (P.S. 113-54) 29. Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 30. Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 31. Lead-Safe Housing for Kids Act (S. 1845) 32. Supporting Working Moms Act (S. 2122/H.R. 3255) 33. Championing Healthy Kids Act (H.R. 3922) 34. Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 35. An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 115- 96) 36. Tax Cuts and Jobs Act (Public Law 115-97) 37. Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 38. Vaccine Access Improvement Act (H.R. 4993) 39. Relief from New Source Performance Standards Act (H.R. 453) 40. Strategies to Address Antimicrobial Resistance (S. 2469) 41. Opioid Quota Reform Act (S. 2535) 42. Hospital Preparedness Program Reauthorization Act (H.R. 4776) 43. Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 44. Opioid Crisis Response Act of 2018 (S. 2680) 45. Agriculture and Nutrition Act (H.R. 2) 46. Agriculture Improvement Act (S. 3042) 47. SECURE Act (H.R. 5998) 48. Trauma-Informed Care for Children and Families Act (S. 774) 49. SUPPORT for Patients and Communities Act (H.R. 6) 50. Centers for Disease Control Emergency Response Act (S. 3161) 51. LABEL Opioids Act (S. 3428) 52. Relief from New Source Performance Standards Act (S. 1857) 53. Outdoors for All Act (S. 3499) 54. The MOMMA Act (H.R. 5977) 55. Preventing Maternal Deaths Act (H.R. 1318) 56. Medicare Access to Vaccines Equity Act (not yet introduced) 57. The Support Act (H.R. 6) 58. Climate Change Health Protection and Promotion Act (S. 529) 59. NURSE Act (H.R. 1597) 60. Investing for the People Act (H.R. 2021) 61. Child Care for Working Families Act (H.R. 365/S. 568) 62. FAMILY Act (H.R. 1185/S. 463) 63. Transportation Alternatives Enhancement Act (S. 1098) 64. Lower Health Care Costs Act (S. 1895) 65. LIFT America Act (H.R 2479) 66. Public Health Funding Restoration Act (H.R. 3447/S. 1944) 67. Supporting Older Americans Act of 2020 (HR 4334) 68. Campus Prevention and Recovery Services for Students Act (H.R. 3591) 69. Healthier Students for Stronger Campuses Act (S. 1281) 70. Saving Lives Through Better Data Act (S. 1793) 71. VACCINES Act (H.R. 2862) 72. DISARM Act (H.R. 4100/S. 1712) 73. Community Access, Resources, and Education for Families Act (H.R. 3117) 74. Protecting Seniors Through Immunization Act (S. 1872) 75. Tobacco-Free Youth Act (S. 1541) 76. Tobacco to 21 Act (H.R. 2411/S. 1258) 77. Investing for People Act (H.R. 2021) 78. School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 79. Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) 80. Social Determinants Accelerator Act (H.R. 4004) 81. Mental Health Professionals Workforce Shortage Loan Repayment Act (H.R. 2431) 82. The UNDERSTAND Act (S. 1323) 83. Americas Transportation Infrastructure Act (S. 2302) 84. Barriers to Suicide Act of 2019 (H.R. 4309) 85. Promoting Physical Activity for Americans Act (S. 1608/H.R. 2891) 86. Public Health Infrastructure Modernization Act of 2019 (H.R. 5321) 87. Supporting Healthy Mothers and Infants Act (H.R. 5249) 88. Lead-Free Future Act (H.R. 4416) 89. Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R. 4768) 90. Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide (H. Res. 592) 91. Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) 92. Families First Coronavirus Response Act (H.R. 6201) 93. Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748) 94. Connecting Americas Transportation Infrastructure Act (S. 2302) 95. Improving Access to Remote Behavioral Health Treatment Act (S. 2244/H.R. 4131) 96. National Suicide Hotline Designation Act (S. 2661/H.R. 4194) 97. Suicide Prevention Lifeline Improvement Act (H.R. 4564) 98. Campaign to Prevent Suicide Act (H.R. 4585) 99. Medicaid Reentry Act (H.R. 1329) 100. Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767) 101. Mental Health Services for Students Act (S. 1122/H.R. 1109) 102. Suicide Training and Awareness Nationally Delivered for Universal Prevention (STANDUP) Act (S. 2492/H.R. 2599) 103. Mental Health Parity Compliance Act (S. 1737/H.R. 3165) 104. Behavioral Health Transparency Act (S. 1576/H.R. 2874) 105. Medicare Mental Health Access Act (S. 2772/H.R. 884) 106. Public Health Emergency Response and Accountability Act (S. 3309) 107. Family Violence Prevention and Services Improvement Act (H.R. 5041) 108. Protecting the Health of Americas Older Adults During COVID-19 and Beyond Act (H.R. 6935) 109. Improving Social Determinants Act (H.R. 6561) 110. Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H.Con.Res.100) 111. FY 2021 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (TBD) 112. Better Tools for Healthy Living Act (S. 1805) 113. The WIC Act (S. 2358) 114. Health Equity and Accountability Act (H.R. 6637) 115. Paycheck Protection Program and Health Care Enhancement Act (H.R. 266) 116. The HEROES Act (H.R.6800) 117. Community Solutions for COVID-19 Act (H.R.7077/S.3877) 118. The Black Maternal Health Momnibus Act of 2020 (H.R. 6142) 119. COVID-19 Bias and Anti-Racism Training Act (S.___) 120. Urging the establishment of a United States Commission on Truth, Racial Healing, and Transformation (H. Con. Res. 100) 121. Community Immunity During COVID-19 Act of 2020 (H.R._____) 122. Public Safety Officer Support Act (H.R. 7568) 123. COVID-19 Behavioral Health Support Act (S. 4059) 124. Public Health Workforce Loan Repayment Act (H.R. 6578) 125. Strengthening the Public Health Workforce Act (S. 3737) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, NIMH, Education, USDA, DHS, FEMA, and SAMHSA

Client expense: $32,208 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Office of Management & Budget (OMB), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Transportation, Dept of (DOT)

H.R. 3, Lower Drug Costs Now Act of 2019 H.R. 19/S. 3129, Lower Costs, More Cures Act of 2019 H.R. 275, Medicare Prescription Drug Price Negotiation Act of 2019 H.R. 448/S. 99, Medicare Drug Price Negotiation Act H.R. 748/ S. 3548, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 1346, Medicare Buy-In and Health Care Stabilization Act of 2019 H.R. 1384, Medicare for All Act of 2019 H.R. 1398/S. 172, Health Insurance Tax Relief Act of 2019 H.R. 1425, Patient Protection and Affordable Care Enhancement Act H.R. 1865, Further Consolidated Appropriations Act, 2020 H.R. 1922/S. 1089, Restoring Access to Medication Act of 2019 H.R. 1985, Family Savings for Kids and Seniors Act H.R. 2207, Protect Medical Innovation Act of 2019 H.R. 3030, Patient-Centered Outcomes Research Extension Act of 2019 H.R. 6074, Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 H.R. 6201, Families First Coronavirus Response Act H.R. 6800, Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act S. 12, Health Savings Act of 2019 S. 61, Safe and Affordable Drugs from Canada Act of 2019 S. 62, Empowering Medicare Seniors to Negotiate Drug Prices Act of 2019 S. 64, Preserve Access to Affordable Generics and Biosimilars Act S. 80, Jobs and Premium Protection Act, including provisions relating to repeal of the annual fee on health insurance providers enacted by the Patient Protection and Affordable Care Act S. 340, Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 S. 344, Hatch-Waxman Integrity Act of 2019 S. 470, Medicare at 50 Act S. 684, Middle Class Health Benefits Tax Repeal Act of 2019 S. 692, Protect Medical Innovation Act of 2019 S. 1416, Affordable Prescriptions for Patients Act of 2019 S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2543, Prescription Drug Pricing Reduction Act of 2019 S. 2897, Patient-Centered Outcomes Research Institute Reauthorization Act S. 3200, Chronic Disease Management Act of 2020 Potential legislation similar to H.R. 2911/S. 1697, Small Business Healthcare Relief Act (114th Cong.) Proposed regulation on the Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2020 (84 Fed. Reg. 227-321, January 24, 2019) Proposed regulations on Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; interoperability and patient access for Medicare advantage organization and Medicaid managed care plans, state Medicaid agencies, CHIP agencies and CHIP managed care entities, issuers of qualified health plans in the federally-facilitated exchanges and health care providers; supplement and extension of comment period (84 Federal Register 16,834, April 23, 2019) Proposed regulations on Medicare modernizing and clarifying physician self-referral regulations (84 Fed. Reg. 55,766-55,847, October 17, 2019) Proposed regulation on Patient Protection and Affordable Care Act; HHS notice of benefit and payment parameters for 2021; notice requirement for non-federal governmental plans (85 Fed. Reg. 7,088-7,159, February 6, 2020) Various issues relating to Patient Protection and Affordable Care Act (P.L. 111-148) and the Health Care and Education Affordability Reconciliation Act of 2010 (P.L. 111-152), including the employer-sponsored health care system, implementation of regulatory process, provider network adequacy, delivery system reform, health savings account (HSAs), health reimbursement account (HRAs), and flexible spending account (FSAs) changes, IPAB, employer mandate, reporting requirements for issuers and applicable large employers, premium stabilization programs, medical loss ratio, medical malpractice reform, exchanges, the impact on small business, the Small Business Tax Credit, section 1332 waivers, section 1557 on nondiscrimination, caps on compensation deductibility required under section 9014, incompleteness or inaccuracy of cost impact analysis, lack of quantified benefit analysis, and need for empirical data sources on which to base costs and benefits, the Cost Sharing Reduction (CSR) program, the section 9010 Health Insurance Providers Fee or Health Insurance Tax (HIT), 40% excise tax on high-cost employer-sponsored health coverage (Cadillac tax); medical device tax; protect Medicare Part Ds Non-Interference Clause from repeal, proposed rule regarding section 1557; Public Health Services Act (P.L.78-410), Internal Revenue Code and the Employee Retirement Income Security Act (ERISA) (P.L. 93-406), regarding regulatory process and legislative corrections to ERISA preemption, changes to Medicare Advantage and Parts B, C, and D, including rebates and non-interference with prescription drug prices, entitlement reform, health information technology, telemedicine services in Medicare, and coordination and disease management programs; association health plans; importation of foreign pharmaceuticals into the United States and preemptive authority of federal food and drug regulations; balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; legislation addressing mental health parity; inclusion of prescription drug pricing on 2019 congressional agenda; reauthorization of the Patient Centered Outcomes Research Institute; (PCORI); potential premium reduction/reinsurance program to reduce health insurance premiums; medical hospital outpatient prospective payment system for CY 2020; drug pricing; potential healthcare pricing proposals, including a medicaid rebate cap, spread pricing, and inflation penalty; comments on Medicare and State Healthcare Programs: fraud and abuse; revisions to safe harbors under the anti-kickback statute, and civil monetary penalty rules regarding beneficiary inducements; comments on Medicare Program; modernizing and clarifying the physician self-referral regulations; comments on CMS proposed Medicaid fiscal accountability regulation; comments on CMS proposed transparency in coverage rule; comments on HHS notice of benefit and payment parameters for 2021; transparency in coverage; Medicaid fiscal accountability regulations; issues relating to the coronavirus pandemic, including testing, liability protection, and temporary COBRA subsidies; Public Health and Social Services Emergency Fund (PHSSEF); health insurance coverage during the coronavirus pandemic; health legislative priorities for the potential Phase 4 coronavirus relief package; provisions relating to Health Savings Accounts (HSA) and Flexible Spending Arrangements (FSA) in the Coronavirus, Aid, Relief, and Economic Security (CARES) Act (P.L. 116-136); FCCs COVID-19 Telehealth Program; Federal Emergency Management Agencys (FEMA) temporary rule regarding Prioritization and Allocation of Certain Scarce or Threatened Health and Medical Resources for Domestic Use

Client expense: $12,300,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Army, Dept of (Corps of Engineers), Bureau of Citizenship & Immigration Services (BCIS), Bureau of Industry and Security (BIS), Bureau of Labor Statistics (BLS), Bureau of Reclamation, Commerce, Dept of (DOC), Commodity Futures Trading Commission (CFTC), Consumer Financial Protection Bureau (CFPB), Council on Environmental Quality (CEQ), Defense, Dept of (DOD), Education, Dept of, Energy, Dept of, Environmental Protection Agency (EPA), Equal Employment Opportunity Commission (EEOC), Executive Office of the President (EOP), Federal Aviation Administration (FAA), Federal Communications Commission (FCC), Federal Deposit Insurance Corporation (FDIC), Federal Emergency Management Agency (FEMA), Federal Energy Regulatory Commission (FERC), Federal Motor Carrier Safety Administration, Federal Reserve System, Federal Trade Commission (FTC), General Services Administration (GSA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Housing & Urban Development, Dept of (HUD), Interior, Dept of (DOI), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Economic Council (NEC), Natl Institute of Standards & Technology (NIST), Natl Labor Relations Board (NLRB), Natl Security Council (NSC), Natl Telecommunications & Information Administration (NTIA), Office of Management & Budget (OMB), Office of Science & Technology Policy (OSTP), Office of the Comptroller of the Currency (OCC), Patent & Trademark Office (PTO), Pension Benefit Guaranty Corporation (PBGC), SENATE, Securities & Exchange Commission (SEC), Small Business Administration (SBA), State, Dept of (DOS), Transportation Security Administration (TSA), Transportation, Dept of (DOT), Treasury, Dept of, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. Trade Representative (USTR), White House Office

Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Congressional outreach and monitoring related to the tobacco industry. Monitored the following: -Implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). -Federal and legislative action related to the marketing and advertising of tobacco products. -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act. -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) -FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring regarding: -Coronavirus and related economic impacts; -Stimulus provisions in relief bills, such as P.L. 116-136, Coronavirus Aid, Relief, and Economic Security Act (CARES Act) and H.R. 6800, The Heroes Act. Outreach and monitoring related to FDA operations and tobacco policy on the following issues: proposed flavor restrictions, online sales bans, and tobacco product user fees. Monitored the following: S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. S. 655 / H.R. 1498, SAFE Kids Act. S. 1541, Tobacco-Free Youth Act. S. 2463, E-Cigarette Tax Parity Act. S. 2517, Tobacco Tax Equity Act of 2019. S. 3174, Reversing the Youth Tobacco Epidemic Act of 2020. H.R. 293, Youth Vaping Prevention Act of 2019. H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019. H.R. 4742, Protecting American Lungs Act of 2019.

Client expense: $300,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 9 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 S. 1541 Tobacco Free Youth Act S. 1258 / H.R. 2411 Tobacco to 21 Act S. 655, SAFE Kids Act H.R. 2084 To amend the Federal Food, Drug, and Cosmetic Act to raise the minimum age restriction with respect to the sale of tobacco products, and for other purposes. H.R. 1854 Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019 FDA Tobacco Deeming Rule HR 2411 Tobacco to 21 Act H.R. 2339 Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 293 Youth Vaping Prevention Act of 2019 H.R. 1498 / S. 655 SAFE Kids Act H.R. 4272 H.R. 2463 HR 1856 Domestic Priorities and International Assistance Minibus Appropriations, Title F, section 605, Sale of Tobacco Products to Individuals under age of 21. Guidance on Flavored Cigars Cigar Excise Taxes

Client expense: $45,000 · Firm income: Not reported

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Ending Nicotine Dependence from Electronic Delivery Systems (End ENDS) Act (H.R. 4264), Reversing the Youth Tobacco Epidemic Act (H.R. 2339/S. 3174), SAFE Kids Act (H.R. 1498/S. 655), Smoke Free Schools Act (S. 1832/H.R. 4019), Tobacco Free Youth Act (S. 1541), Protecting American Lungs Act (H.R. 4742), Quit Because of COVID-19 Act (H.R. 7286), e-cigarettes, and premarket application of tobacco products

Client expense: $40,000 · Firm income: Not reported

Government targets: Education, Dept of, Environmental Protection Agency (EPA), Federal Communications Commission (FCC), Federal Emergency Management Agency (FEMA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Internal Revenue Service (IRS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, White House Office

H.Res.896, Reaffirming support of fundamental United States principles at the United Nations and encouraging the World Health Organization to embrace technological advancements in tobacco control H.R. 293, Youth Vaping Prevention Act S. 655/H.R. 1498, SAFE Kids Act S. 1965/H.R. 1642, Combatting Illicit Trade in Tobacco Products Act S. 916/H.R. 1897, MOMMAS Act; provisions related to the taxation of tobacco products H.R. 2084, Stopping Consumption of Tobacco by Teens (SCOTT) Act S. 1048/H.R. 2111, Preventing Opportunities for Teen E-Cigarette and Tobacco Addiction (PROTECT) Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act H.R. 2726, Banning Smoking on Amtrak Act S. 1823/H.R. 3229, Children Dont Belong on Tobacco Farms Act S. 1253/H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act S. 1832/H.R. 4019, Smoke-Free Schools Act H.R. 4249, Stop Vaping Ads Act S. 2517/H.R. 4425, Tobacco Tax Parity Act/Quell Underage Inhaling of Toxic Substances (QUITS) Act H.R. 4624, Ending Nicotine Dependence from Electronic Nicotine Delivery Systems (END ENDS) Act H.R. 4742, Imposition of Tax on Nicotine for Use in Vapor Act H.R. 5005, Prevent Vape Use Act S. 3096/H.R. 5482, PREVENT (Providing Resources to End the Vaping Epidemic Now for Teenagers) Act S. 3223/H.R. 5721, Resources to Prevent Youth Vaping Act S. 3263/H.R. 5845, Break Free from Plastic Pollution Act H.R. 5963, E-Cigarette Oversight and Accountability Act S. 616, E-Cigarette Youth Protection Act S. 1258/H.R. 2411, Tobacco to 21 Act S. 1541, Tobacco-Free Youth Act S. 1895, Lower Health Care Costs Act S. 2463, E-Cigarette Tax Parity Act S. 2519, Ending New Nicotine Dependencies (ENND) Act S. 2536, E-Cigarette Device Standards Act S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act Implementation of P.L. 111-31, the Tobacco Control Act Issues surrounding FDA Premarket Tobacco Product Applications (PMTA) and Modified Risk Tobacco Product (MRTP) compliance policies Issues surrounding taxation of tobacco products January 2020 FDA guidance on flavors in vapor products Issues surrounding implementation of P.L. 111-31, the Tobacco Control Act January 2020 FDA guidance on flavors in vapor products FDA proposed rule concerning N-Nitrosonornicotine (NNN) Levels in Smokeless Tobacco Products ANPRMS for Docket Nos. FDA-2017-N-6189 and FDA-2017-N-6565 Draft Guidance for Certain Marketed Tobacco Products, Docket No. FDA-2018-D-3244-0001

Client expense: $450,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR), White House Office

Regulation of electronic nicotine delivery system products as a less harmful alternative for adult smokers; Issues related to enforcement of illicit tobacco products; H.R. 293, Youth Vaping Prevention Act of 2019; H.R. 1498/S. 655, SAFE Kids Act; H.R. 1642/S. 1965, Combating the Illicit Trade in Tobacco Products Act; H.R. 1897/S. 916, MOMMAs Act; provisions related to taxation of tobacco products; H.R. 2084, SCOTT Act of 2019; H.R. 2111/S. 1048, PROTECT Act; H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019; H.R. 3700/S. 2106, a bill to prohibit smoking on the premises of any facility of the Veterans Health Administration; H.R. 4249, Stop Vaping Ads Act of 2019; H.R. 4425, Quell Underage Inhaling of Toxic Substances Act of 2019; H.R. 6637, The Health Equity and Accountability Act, provisions related to taxation of tobacco products; S. 616, E-cigarette Youth Protection Act; S. 1541, Tobacco Free Youth Act; S. 1895, Lower Health Care Costs Act; provisions related to the regulation of tobacco products; S. 2519, Prohibiting Non-tobacco E-cigarette Flavors; S. 2536, E-Cigarette Device Standards Act of 2019; and S. 2550, No Tax Subsidies for E-Cigarette and Tobacco Ads Act.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Tobacco use prevention and smoking cessation; FDA regulation of tobacco; Tobacco 21 legislation, electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Appropriations, including S.1258, S. 1541, S. 655, S. 1832, H.R. 2339, and H.R. 2339

Client expense: $540,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE, White House Office

Tobacco issues in general S. 1541, The Tobacco Free Youth Act H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019 H.R. 2411, Tobacco to 21 Act HR 4742, Protecting American Lungs Act of 2019

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Congressional outreach and monitoring related to the tobacco industry. Outreach and monitoring of administrative and legislative action related to menthol cigarettes. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor administrative and legislative action related to: -Marketing and advertising of tobacco products; -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act; -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) - FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring related to the following: -S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. -S. 655 / H.R. 1498, SAFE Kids Act. -S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. -S. 1541, Tobacco-Free Youth Act. -H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. -S. 2517, Tobacco Tax Equity Act of 2019 -S. 2463, E-Cigarette Tax Parity Act -H.R. 4742, Protecting American Lungs Act of 2019 -H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 -Legislative outreach related to the implementation of H.R. 748, CARES Act (P.L. 116-136), H.R. 266 Paycheck Protection Program and Health Care Enhancement Act (PL 116-139), H.R. 6800 The Heroes Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Congressional outreach and monitoring related to the tobacco industry. Outreach and monitoring of administrative and legislative action related to menthol cigarettes. Monitor the implementation of Family Smoking Prevention and Tobacco Control Act (P.L.113-3). Monitor administrative and legislative action related to: -Marketing and advertising of tobacco products; -FDA action on deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act; -FDA's Advance Notice of Proposed Rulemaking, Tobacco Product Standard for Nicotine Level of Combusted Cigarettes (Docket No. FDA2017N6189) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Flavors in Tobacco Products (Docket No. FDA2017N6565) -FDA's Advance Notice of Proposed Rulemaking, Regulation of Premium Cigars (Docket No. FDA2017N6107) - FDAs enforcement priorities for ENDS and other deemed products (Docket No. FDA2019D0661) -FDA's Final Rulemaking related to Cigarette Health Warning Labels (Docket No. FDA2019N3065) Outreach and monitoring related to the following: -S. 9 / H.R. 1854, Traditional Cigar Manufacturing and Small Business Jobs Preservation Act of 2019. -S. 655 / H.R. 1498, SAFE Kids Act. -S. 1253 / H.R. 3942, Preventing Online Sales of E-Cigarettes to Children Act. -S. 1541, Tobacco-Free Youth Act. -H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019. -S. 2517, Tobacco Tax Equity Act of 2019 -S. 2463, E-Cigarette Tax Parity Act -H.R. 4742, Protecting American Lungs Act of 2019 -H.R. 2339, Protecting American Lungs and Reversing the Youth Tobacco Epidemic Act of 2020 -Legislative outreach related to the implementation of H.R. 748, CARES Act (P.L. 116-136), H.R. 266 Paycheck Protection Program and Health Care Enhancement Act (PL 116-139), H.R. 6800 The Heroes Act

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE